Inventor
SUSSMAN DJANGO
US20 patents
⚠️ This page may combine multiple inventors who share the name “SUSSMAN DJANGO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEATTLE GENETICS INC
10 patentsUS9061074B2Jun 23, 2015
Variant target binding agents and uses thereof
SEATTLE GENETICS INC13 citations92
US9816069B2Nov 14, 2017
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
SEATTLE GENETICS INC6 citations82
US9587019B2Mar 7, 2017
CD33 antibodies and use of same to treat cancer
SEATTLE GENETICS INC7 citations82
US8993326B2Mar 31, 2015
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
SEATTLE GENETICS INC9 citations82
US10407505B2Sep 10, 2019
Variant target binding agents and uses thereof
SEATTLE GENETICS INC1 citations73
US11325980B2May 10, 2022
Combination therapy using a LIV1-ADC and a chemotherapeutic
SEATTLE GENETICS INC2 citations72
US10443035B2Oct 15, 2019
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
SEATTLE GENETICS INC2 citations71
US9783608B2Oct 10, 2017
Humanized antibodies to LIV-1 and use of same to treat cancer
SEATTLE GENETICS INC3 citations70
US10787514B2Sep 29, 2020
CD33 antibodies and use of same to treat cancer
SEATTLE GENETICS INC1 citations61
US10912842B2Feb 9, 2021
CD123 antibodies and conjugates thereof
SEATTLE GENETICS INC1 citations60
SEAGEN INC
6 patentsUS11078291B2Aug 3, 2021
BCMA antibodies and use of same to treat cancer and immunological disorders
SEAGEN INC8 citations82
USRE48959EMar 8, 2022
Humanized antibodies to LIV-1 and use of same to treat cancer
SEAGEN INC4 citations81
US11319526B2May 3, 2022
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
SEAGEN INC2 citations71
US11767365B2Sep 26, 2023
BCMA antibodies and use of same to treat cancer and immunological disorders
SEAGEN INC1 citations61
US11938194B2Mar 26, 2024
Cysteine mutated antibodies for conjugation
SEAGEN INC0 citations51
US11351269B2Jun 7, 2022
Anti-NTB-A antibodies and related compositions and methods
SEAGEN INC0 citations51
ALLEY STEPHEN C
2 patentsUS8163551B2Apr 24, 2012
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
ALLEY STEPHEN C48 citations95
US8574907B2Nov 5, 2013
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
ALLEY STEPHEN C19 citations89